APA aipamena

Sinilnikova, O. M., Antoniou, A. C., Simard, J., Healey, S., Léoné, M., Sinnett, D., . . . Stoppa-Lyonnet, D. (2009). The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Nature Publishing Group.

Chicago Style aipamena

Sinilnikova, O M., et al. The TP53 Arg72Pro and MDM2 309G>T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Nature Publishing Group, 2009.

MLA aipamena

Sinilnikova, O M., et al. The TP53 Arg72Pro and MDM2 309G>T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Nature Publishing Group, 2009.